Related Experiment Videos
A review of clinically relevant cardiac biochemical markers
William W Chu1, Robert S Dieter, Charles K Stone
1Section of Cardiovascular Medicine, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Insights
Diagnosing acute myocardial infarction (MI) is complex. Cardiac troponin I shows promise as a specific biomarker for MI diagnosis, but more trials are needed to confirm its value.
Area of Science:
- Cardiology
- Biochemistry
- Emergency Medicine
Background:
- Acute coronary syndromes are a leading cause of mortality and healthcare costs.
- Diagnosing acute myocardial infarction (MI) is challenging due to atypical symptoms and nonspecific ECG changes in many patients.
- Cardiac biochemical markers are crucial for MI diagnosis and risk stratification.
Purpose of the Study:
- To review the characteristics of various cardiac markers.
- To compare the utility of different cardiac markers in diagnosing acute MI.
- To highlight the role of cardiac troponin I as a potentially highly specific marker for acute MI.
Main Methods:
- Literature review of cardiac biochemical markers.
- Comparison of diagnostic performance of different markers.
- Focus on cardiac troponin I's specificity.
Main Results:
- Cardiac troponin I is identified as the most cardiac-specific marker currently available for acute MI diagnosis.
- Existing diagnostic approaches for chest pain in the Emergency Department (ED) are complex and not fully optimized.
- The ideal cardiac marker and diagnostic strategy for chest pain in the ED remain under investigation.
Conclusions:
- Cardiac troponin I appears to be the most specific biomarker for acute MI.
- Further prospective, randomized, multicenter trials are essential.
- Confirming the value of troponins and other strategies is needed for early acute MI diagnosis.
Abstract:
Acute coronary syndromes remain the leading cause of mortality in the United States and represent an enormous cost to the health care system. Despite decades of investigation into the diagnosis of acute myocardial infarction (MI), the diagnostic process is still quite complex because the majority of patients with chest pain fall in the low or medium risk category with atypical symptoms and nonspecific electrocardiogram (ECG) changes. Cardiac biochemical markers play an important role in helping physicians make the diagnosis and stratify the risk to patients. However, the ideal cardiac marker and the best diagnostic approach to patients with chest pain in the Emergency Department (ED) remain elusive. Currently, among many cardiac markers, cardiac troponin I seems the most cardiac-specific in the diagnosis of acute MI. This article is focused on reviewing the characteristics of different cardiac markers and comparison of their usages in the diagnosis of acute MI. However, since this field is large and rapidly expanding, it is impossible to cover every aspect of cardiac markers. As the search for the most efficacious, specific and cost-effective means to approach patients with chest pain continues, further prospective, randomized, multicenter trials are needed to confirm the value of troponins and other diagnostic strategies in the early diagnosis of acute MI.